Literature DB >> 3858834

Generation of functional clonal cell lines from human bone marrow stroma.

K Harigaya, H Handa.   

Abstract

Five clonal human bone marrow stromal cell lines were isolated from the adherent cell populations in long-term liquid cultures after transfection with the recombinant plasmid pSV3gpt. All the cell-line feeder layers and their conditioned media stimulated the proliferation of committed granulomonocytic stem cells (CFUc) from human bone marrow. The size and number of early erythroid stem cell (BFUe)-derived colonies were significantly increased when in the presence of 10% conditioned medium from the cell lines. Furthermore, a substantial number of mixed colonies with erythroid components were observed in the cultures in the presence of erythropoietin and conditioned medium. These findings suggest that the human bone marrow stromal cell lines obtained after transfection with pSV3gpt may be extremely useful in identifying the hematopoietic factors derived from the hematopoietic microenvironment and in analyzing their mechanism of action.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3858834      PMCID: PMC397799          DOI: 10.1073/pnas.82.10.3477

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  In vitro proliferation of haemopoietic cells in the presence of adherent cell layers. I. Culture conditions and strain dependence.

Authors:  J Reimann; H Burger
Journal:  Exp Hematol       Date:  1979-01       Impact factor: 3.084

2.  Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells.

Authors:  A W Burgess; E M Wilson; D Metcalf
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

3.  Conditions controlling the proliferation of haemopoietic stem cells in vitro.

Authors:  T M Dexter; T D Allen; L G Lajtha
Journal:  J Cell Physiol       Date:  1977-06       Impact factor: 6.384

4.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

5.  Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.

Authors:  S D Wright; P E Rao; W C Van Voorhis; L S Craigmyle; K Iida; M A Talle; E F Westberg; G Goldstein; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  Blood cell development. The message in the medium.

Authors:  T M Dexter
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

7.  Hormonal responsiveness of a preadipose cell line derived from newborn mouse calvaria.

Authors:  H A Kodama; Y Amagai; H Koyama; S Kasai
Journal:  J Cell Physiol       Date:  1982-07       Impact factor: 6.384

8.  Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: factors influencing growth and adipogenesis in vitro.

Authors:  M Lanotte; D Scott; T M Dexter; T D Allen
Journal:  J Cell Physiol       Date:  1982-05       Impact factor: 6.384

9.  Murine bone marrow cell line producing colony-stimulating factor.

Authors:  K Harigaya; E P Cronkite; M E Miller; R K Shadduck
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Long-term culture of human bone marrow cells.

Authors:  S Gartner; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

  10 in total
  16 in total

1.  Immortalization of brain capillary endothelial cells with maintenance of structural characteristics of the blood-brain barrier endothelium.

Authors:  O Durieu-Trautmann; N Foignant-Chaverot; J Perdomo; P Gounon; A D Strosberg; P O Couraud
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

2.  Establishment of an osteogenic cell line derived from adult mouse bone marrow stroma by use of a recombinant retrovirus.

Authors:  E Mathieu; G Schoeters; F vander Plaetse; J Merregaert
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

3.  Clonal populations of the mouse mammary cell line, COMMA-D, which retain capability of morphogenesis in vivo.

Authors:  K G Danielson; J E Knepper; F S Kittrell; J S Butel; D Medina; E M Durban
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

4.  TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells.

Authors:  Shuanhu Zhou
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

5.  Inhibition of adipocytogenesis by canonical WNT signaling in human mesenchymal stem cells.

Authors:  Longxiang Shen; Julie Glowacki; Shuanhu Zhou
Journal:  Exp Cell Res       Date:  2011-05-27       Impact factor: 3.905

6.  Interleukin-6 (IL-6) production in carcinoma of the cervix.

Authors:  H Takano; K Harigaya; G Ishii; Y Sugaya; S Soeta; T Nunoyama; H Shirasawa; K Shimizu; H Tokita; B Simizu; A Mikata; S Sekiya
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

Review 7.  Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells.

Authors:  Shuo Geng; Shuanhu Zhou; Zhenggang Bi; Julie Glowacki
Journal:  Metabolism       Date:  2013-01-30       Impact factor: 8.694

8.  Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma.

Authors:  J Teixidó; M E Hemler; J S Greenberger; P Anklesaria
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.

Authors:  Bao Hoang; Li Zhu; Yijiang Shi; Patrick Frost; Huajun Yan; Sanjai Sharma; Sherven Sharma; Lee Goodglick; Steven Dubinett; Alan Lichtenstein
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

10.  Differentiation stage and lineage-specific inhibitor from the stroma of mouse bone marrow that restricts lymphoma cell growth.

Authors:  D Zipori; M Tamir; J Toledo; T Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.